Rockwell Medical, Inc. (RMTI) stock
RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3081% below fair value
$6.10−0.51 (-7.72%)
Close on Nov 18, 2026Market cap $24.59MP/E –Yield –
Rockwell Medical operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Rockwell Medical's operating cash flow for the twelve months ending Jun 30, 2026 was $2.90M, down 17.2% year over year. For fiscal 2025 it was -$659.00K, down 115.7% from the year before. The highest annual figure on record is $4.26M in fiscal 2014.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$659.00K | -115.7% |
| FY2024 | Dec 31, 2024 | $4.20M | – |
| FY2023 | Dec 31, 2023 | -$9.41M | – |
| FY2022 | Dec 31, 2022 | -$16.93M | – |
| FY2021 | Dec 31, 2021 | -$33.53M | – |
| FY2020 | Dec 31, 2020 | -$29.64M | – |
| FY2019 | Dec 31, 2019 | -$27.25M | – |
| FY2018 | Dec 31, 2018 | -$20.42M | – |
| FY2017 | Dec 31, 2017 | -$21.11M | – |
| FY2016 | Dec 31, 2016 | -$12.45M | – |
| FY2015 | Dec 31, 2015 | -$13.33M | -413.0% |
| FY2014 | Dec 31, 2014 | $4.26M | – |
| FY2013 | Dec 31, 2013 | -$50.66M | – |
| FY2012 | Dec 31, 2012 | -$30.75M | – |
| FY2011 | Dec 31, 2011 | -$10.78M | -613.3% |
| FY2010 | Dec 31, 2010 | $2.10M | – |
| FY2009 | Dec 31, 2009 | -$1.43M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.08M | +12.8% |
| Q1 FY2026 | Mar 31, 2026 | -$167.00K | – |
| Q4 FY2025 | Dec 31, 2025 | $2.29M | +164.9% |
| Q3 FY2025 | Sep 30, 2025 | -$1.31M | -130.6% |
| Q2 FY2025 | Jun 30, 2025 | $1.84M | +27.9% |
| Q1 FY2025 | Mar 31, 2025 | -$3.49M | – |
| Q4 FY2024 | Dec 31, 2024 | $865.00K | – |
| Q3 FY2024 | Sep 30, 2024 | $4.28M | – |
| Q2 FY2024 | Jun 30, 2024 | $1.44M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.38M | – |
| Q4 FY2023 | Dec 31, 2023 | -$43.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.75M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.74M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.88M | – |
| Q4 FY2022 | Dec 31, 2022 | -$112.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.10M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.90M | – |
| Q1 FY2022 | Mar 31, 2022 | -$9.81M | – |
| Q4 FY2021 | Dec 31, 2021 | -$9.03M | – |
| Q3 FY2021 | Sep 30, 2021 | -$7.08M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.94M | – |
| Q1 FY2021 | Mar 31, 2021 | -$12.50M | – |
| Q4 FY2020 | Dec 31, 2020 | -$8.57M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.92M | – |
| Q2 FY2020 | Jun 30, 2020 | -$9.62M | – |
| Q1 FY2020 | Mar 31, 2020 | -$6.54M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.30M | – |
| Q3 FY2019 | Sep 30, 2019 | -$6.18M | – |
| Q2 FY2019 | Jun 30, 2019 | -$10.35M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.42M | – |
| Q4 FY2018 | Dec 31, 2018 | -$5.78M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.78M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.25M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.61M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.81M | -994.5% |
| Q3 FY2017 | Sep 30, 2017 | -$4.18M | – |
| Q2 FY2017 | Jun 30, 2017 | -$7.04M | – |
| Q1 FY2017 | Mar 31, 2017 | -$5.08M | – |
| Q4 FY2016 | Dec 31, 2016 | $537.78K | – |
| Q3 FY2016 | Sep 30, 2016 | -$6.70M | – |
See a number that looks wrong?